Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Helicobacter pylori eradication and insulin resistance
2015-000197-35Phase 4Completed
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of pantoprazole, clarithromycin and amoxicillin in Helicobacter pylori infection and insulin resistance (IR) (2 arms), sponsored by Sant'Orsola-Malpighi University Hospital. Primary endpoint: Effect of Helicobacter pylori eradication on insulin resistance. Started Mar 2016; status: completed.
02
Drugs
pantoprazoleclarithromycinamoxicillin
03
Conditions
Helicobacter pylori infectioninsulin resistance (IR)
Beyond the preview
Go deeper on 2015-000197-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000197-35.